We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+28.53%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.3B
AUM Growth
+$4.26B
(+43%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
13.37%
Top 10 Holdings %
Top 10 Hldgs %
16.38%
Holding
2,145
New
560
Increased
472
Reduced
391
Closed
662
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$139M |
| 2 |
Procter & Gamble
PG
|
+$118M |
| 3 |
Teleflex
TFX
|
+$90.1M |
| 4 |
Microsoft
MSFT
|
+$89.4M |
| 5 |
UBS Group
UBS
|
+$77.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$203M |
| 2 |
AGN
Allergan plc
AGN
|
+$177M |
| 3 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$118M |
| 4 |
Amazon
AMZN
|
+$115M |
| 5 |
Linde
LIN
|
+$89.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.29% |
| 2 | Consumer Discretionary | 15.87% |
| 3 | Technology | 12.26% |
| 4 | Financials | 12.01% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PPL
226
PPL Corp
PPL
$27.3B
| $13.3M | 0.09% |
+513,415
| New | +$13.4M |
|
227
Sensient Technologies
SXT
$5.4B
| $13M | 0.09% |
+249,901
| New | +$11.8M |
|
228
Constellation Brands
STZ
$22.2B
| $12.8M | 0.09% |
73,031
+71,992
| +6,929% | +$12M |
|
229
Biogen
BIIB
$29.9B
| $12.7M | 0.09% |
47,365
-16,987
| -26% | -$5.11M |
|
230
Merck
MRK
$324B
| $12.7M | 0.09% |
171,465
-165,799
| -49% | -$12.5M |
|
231
Mattel
MAT
$4.17B
| $12.6M | 0.09% |
1,299,040
-503,189
| -28% | -$4.57M |
|
232
Nike
NKE
$61.9B
| $12.5M | 0.09% |
127,343
-617,740
| -83% | -$57M |
|
|
VMW
233
DELISTED
VMware, Inc
VMW
| $12.4M | 0.09% |
80,189
+45,620
| +132% | +$6.27M |
|
234
TE Connectivity
TEL
$58.8B
| $12.3M | 0.09% |
150,874
+149,982
| +16,814% | +$11.3M |
|
235
Evergy
EVRG
$20.1B
| $12.3M | 0.09% |
+207,446
| New | +$12.3M |
|
236
Pinterest
PINS
$12.4B
| $12.2M | 0.09% |
+552,503
| New | +$10.8M |
|
237
Avient
AVNT
$3.45B
| $12.2M | 0.09% |
466,191
-87,965
| -16% | -$2.04M |
|
|
TCO
238
DELISTED
Taubman Centers Inc.
TCO
| $12.2M | 0.09% |
322,909
+210,706
| +188% | +$8.61M |
|
|
CXO
239
DELISTED
CONCHO RESOURCES INC.
CXO
| $12.2M | 0.09% |
236,127
+222,200
| +1,595% | +$12.3M |
|
240
Rio Tinto
RIO
$148B
| $12.1M | 0.08% |
215,102
+26,923
| +14% | +$1.36M |
|
241
Dorman Products
DORM
$4.01B
| $11.9M | 0.08% |
177,056
+148,594
| +522% | +$9.56M |
|
242
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.7B
| $11.7M | 0.08% |
87,144
+78,556
| +915% | +$10.2M |
|
243
Asbury Automotive
ABG
$4.19B
| $11.7M | 0.08% |
151,258
-4,672
| -3% | -$314K |
|
|
SGEN
244
DELISTED
Seagen Inc. Common Stock
SGEN
| $11.7M | 0.08% |
+68,740
| New | +$10.3M |
|
245
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
| $11.6M | 0.08% |
142,319
+111,912
| +368% | +$9.02M |
|
246
Spyre Therapeutics
SYRE
$8.87B
| $11.6M | 0.08% |
49,957
+16,391
| +49% | +$3.12M |
|
247
Zillow
Z
$7.04B
| $11.6M | 0.08% |
+200,509
| New | +$9.95M |
|
248
Goldman Sachs
GS
$313B
| $11.5M | 0.08% |
58,335
+39,265
| +206% | +$7.37M |
|
|
BSX.PRA
249
DELISTED
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
| $11.5M | 0.08% |
+110,000
| New | +$11.8M |
|
250
VanEck Junior Gold Miners ETF
GDXJ
$7.06B
| $11.5M | 0.08% |
232,037
+229,134
| +7,893% | +$9.7M |
|
Similar funds
Marshall Wace's Q2 2020 Portfolio in Review
As of Q2 2020, Marshall Wace held 2,145 positions worth $14.3B, up 43% from $10B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $1.91B of net new capital in Q2 2020, opening 560 new positions and adding to 472 existing holdings. Its largest new stake was JPMorgan Chase: 783,355 shares worth $73.7M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was PayPal, an estimated $203M trimmed.
- Marshall Wace's largest Q2 2020 buy was JPMorgan Chase: 783,355 shares worth $73.7M.
- Marshall Wace added most to T-Mobile US in Q2 2020, an estimated $139M increase.
- Marshall Wace's biggest Q2 2020 reduction was PayPal, cutting an estimated $203M.
- Marshall Wace fully exited Allergan plc in Q2 2020, selling an estimated $177M.
- Marshall Wace's ten largest holdings make up 16% of its $14.3B portfolio in Q2 2020.
- Marshall Wace opened 560 new positions and closed 662 in Q2 2020.
- Marshall Wace's portfolio value rose 43% quarter-over-quarter to $14.3B.
Based on Marshall Wace's 13F filing for Q2 2020, filed 13 Aug 2020.